Evidence map›Paper›PMID 40871076›Full record

ArticlePharmaceutics2025

Dual-Cross-Linked Alginate Hydrogels as a Strategy to Improve the Antifungal Properties of Posaconazole.

Katarzyna Sosnowska, Marta Szekalska, Ewelina Piktel, Robert Bucki, Eliza Wolska, Iwona Misztalewska-Turkowicz, Karolina Halina Markiewicz, Agnieszka Zofia Wilczewska, Katarzyna Winnicka

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pharmaceutics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Katarzyna SosnowskaDepartment of Pharmaceutical Technology, Medical University of Białystok, Mickiewicza 2C, 15-222 Białystok, Poland.ORCID 0000-0001-8528-3764
Marta SzekalskaDepartment of Pharmaceutical Technology, Medical University of Białystok, Mickiewicza 2C, 15-222 Białystok, Poland.ORCID 0000-0003-4340-5350
Ewelina PiktelIndependent Laboratory of Nanomedicine, Medical University of Białystok, 15-222 Białystok, Poland.
Robert BuckiDepartment of Medical Microbiology and Nanobiomedical Engineering, Medical University of Białystok, 15-222 Białystok, Poland.ORCID 0000-0001-7664-9226
Eliza WolskaDepartment of Pharmaceutical Technology, Medical University of Gdańsk, Hallera 107, 80-416 Gdańsk, Poland.
Iwona Misztalewska-TurkowiczDepartment of Polymers and Organic Synthesis, Faculty of Chemistry, University of Białystok, Ciołkowskiego 1K, 15-245 Białystok, Poland.ORCID 0000-0001-6191-6053
Karolina Halina MarkiewiczDepartment of Polymers and Organic Synthesis, Faculty of Chemistry, University of Białystok, Ciołkowskiego 1K, 15-245 Białystok, Poland.ORCID 0000-0002-4857-0489
Agnieszka Zofia WilczewskaDepartment of Polymers and Organic Synthesis, Faculty of Chemistry, University of Białystok, Ciołkowskiego 1K, 15-245 Białystok, Poland.
Katarzyna WinnickaDepartment of Pharmaceutical Technology, Medical University of Białystok, Mickiewicza 2C, 15-222 Białystok, Poland.ORCID 0000-0002-1013-610X

Funding

Medical University of Bialystok B.SUB.24.615/01.S
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

cross-linkinghydrogelsposaconazolesodium alginateε-poly-L-lysine

Identifiers

PMID40871076
PMCPMC12389386

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.